These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH. Cancer; 2001 Jun 15; 91(12):2335-42. PubMed ID: 11413523 [Abstract] [Full Text] [Related]
4. Prognostic factors of anaplastic thyroid carcinoma. Kihara M, Miyauchi A, Yamauchi A, Yokomise H. Surg Today; 2004 Jun 15; 34(5):394-8. PubMed ID: 15108075 [Abstract] [Full Text] [Related]
10. Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors. Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J. Head Neck; 2012 Feb 15; 34(2):230-7. PubMed ID: 21500309 [Abstract] [Full Text] [Related]
17. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. World J Surg; 2001 May 15; 25(5):617-22. PubMed ID: 11369989 [Abstract] [Full Text] [Related]